Nyack Hospital Clinical Pharmacy Department
The Clinical Pharmacy Department at Nyack Hospital focuses on individualized drug treatment for patients to maximize the therapy’s effectiveness while minimizing side effects.
The department, established in 2009, focuses on research that translates into improved patient care. Our mission is to carry out research and clinical activities that improve treatment for patients, regardless of age, gender or ethnicity. Our current research focuses on the way in which antimicrobial and anticoagulant drugs work in the body in special populations, including young adults, the obese and dialysis patients.
Our published work includes scientific poster presentations at national and international conferences, including the Interscience Conference on Antimicrobial Agents and Chemotherapy, the annual meeting of the Infectious Disease Society of America, the annual meeting of the American College of Clinical Pharmacy, and the European Congress of Clinical Microbiology and Infectious Diseases.
Nyack Hospital Collaborative Review Article Published in The Lancet Infectious Diseases
Development of a Smart Phone application prototype to individualize antibiotic dosing in critically ill patients based on the results of population pharmacokinetic models and Monte Carlo simulations
Pharmacodynamic(PD) Profiling of Daptomycin(DAP) Against MethicillinResistant Staphylococcus Aureusfor the Treatment of Serious Infections in USA Medical Centers
Population Probability of Target Attainment of Daptomycin (DAP) at Different Levels of Renal Function Against Methicillin Resistant Staphylococcus aureus in European Medical Centers
Dosing of Daptomycin in the Morbidly Obese: Which Body Weight is it?
Model based optimization of Daptomycin dosing during high – intensity renal replacement therapy
Pharmacodynamic profiling of prolonged infusion of Ertapenem in critically ill patients with early onset ventilator associated pneumonia through the use of a population pharmacokinetic model and Monte Carlo simulation
Site -specific target attainment rates of meropenemfor central nervous system infections
Pulmonary target attainment rates of short and extended infusion meropenemregimens based on simulated epithelial lining fluid levels
Selection of optimal empiric antimicrobial therapy against Pseudomonas aeruginosa in the greater New York City area
Successful Target Attainment of Telavancin at Elevated MICs: Fact or
Population Probability of Target Attainment of Telavancinat Different Levels of Renal Function Against MethicillinResistant Staphylococcus aureusin US Medical Centers
Evaluation of Pharmacist Managed Vancomycin Therapy Compared to Physician Managed Dosing in
Establishing Timely and Therapeutic Vancomycin Serum Concentrations at a Community Hospital
For further information about the Pharmacy Services at Nyack Hospital, please call 845.348. 2608.